Risk of Inflammatory Bowel Disease in Psoriasis Patients Treated with Anti-Interleukin-17 Agents: A Bayesian Metaanalysis
View ORCID ProfileN. Gill, M. Pietrosanu, View ORCID ProfileR. Gniadecki
doi: https://doi.org/10.1101/19012179
N. Gill
1Division of Dermatology, Faculty of Medicine, University of Alberta, Edmonton, AB, Canada
M. Pietrosanu
2Department of Mathematical & Statistical Sciences, Faculty of Science, University of Alberta, Edmonton, AB, Canada
R. Gniadecki
1Division of Dermatology, Faculty of Medicine, University of Alberta, Edmonton, AB, Canada
Data Availability
Data used in this study is available in the supplementary materials.
Posted November 19, 2019.
Risk of Inflammatory Bowel Disease in Psoriasis Patients Treated with Anti-Interleukin-17 Agents: A Bayesian Metaanalysis
N. Gill, M. Pietrosanu, R. Gniadecki
medRxiv 19012179; doi: https://doi.org/10.1101/19012179
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2296)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11621)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3623)
- Geriatric Medicine (340)
- Health Economics (622)
- Health Informatics (2329)
- Health Policy (918)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (393)
- Neurology (3389)
- Nursing (193)
- Nutrition (512)
- Oncology (1776)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1012)
- Primary Care Research (409)
- Public and Global Health (6020)
- Radiology and Imaging (1237)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)